INS and metabolic dysfunction-associated steatotic liver disease: APRI was positively correlated with most of the cardiovascular risk parameters [total cholesterol (r=0.534,p<0.0001), LDL-cholesterol (r=0.595, p<0.0001), glucose(r=0.656, p<0.0001), insulin (r=0.523, p<0.0001), HOMA-IR(r=0.549, p<0.0001)] and carotid IMT (r=0.917, p<0.0001) in the NAFLD obese group.